5Y Capital
5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.
Almond Fintech is a developer of a cross-border payment platform that facilitates remittances and payments across various providers and borders. The company's platform offers currency exchange services and ensures interoperability between mobile wallets and financial services. This enables individuals and businesses to send and receive money using their existing wallets, streamlining the process of cross-border transactions. By focusing on enhancing mobile financial services, Almond Fintech aims to simplify and improve the user experience for both personal and business financial activities.
DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.
MedRhythms Inc. is a neuro-rehabilitation company that specializes in neurologic music therapy, utilizing sensors, music, and artificial intelligence to enhance therapeutic outcomes. Founded in 2015 and headquartered in Portland, Maine, the company focuses on patients affected by conditions such as traumatic brain injury, stroke, Parkinson’s disease, and Huntington’s disease. MedRhythms develops evidence-based interventions aimed at improving walking, speech, cognitive abilities, and overall functional outcomes through the intersection of music and neuroscience. By employing innovative technology and direct brain stimulation techniques, the company aims to provide effective rehabilitation solutions that leverage the therapeutic benefits of music for neurological recovery.
Catalant Technologies, Inc. is a Boston-based software company that specializes in providing solutions for strategy execution to global enterprises. Founded in 2013 and formerly known as HourlyNerd, the company offers a platform that assists organizations in transforming their strategic objectives into actionable plans. Catalant's software enables businesses to align work, access both internal and external resources, collaborate effectively, and measure the value of their efforts, facilitating faster execution of mission-critical projects. The platform connects enterprises with a global network of over 65,000 experts and more than 27,000 boutique firms, providing a streamlined approach to sourcing expertise on demand. By leveraging best-in-class tools for talent management, Catalant helps clients improve efficiency and effectiveness in achieving their strategic goals.
Stavvy, Inc. is a financial technology company that specializes in a digital mortgage vendor platform designed to streamline communications and access to vendor data for mortgage banking professionals. The platform offers tools such as Stavvy Connect, which facilitates secure interactions between lenders and their title, settlement, and appraisal vendors, and Stavvy Notarize, which enables real estate professionals to conduct virtual closings and meetings using web conference technology. By eliminating traditional paper processes, Stavvy aims to enhance operational efficiency and compliance while minimizing risks associated with vendor interactions. Founded in 2018 and based in Boston, Massachusetts, the company was formerly known as Stavros Technologies, Inc. before rebranding in August 2020.
Prilenia Therapeutics B.V., a clinical stage biotech company, researches and develops products for movement disorders and neurodegenerative diseases affecting adults and children. It offers Pridopidine, an orally bioavailable small molecule investigational drug for huntington disease, amyotrophic lateral sclerosis, Parkinson’s disease levodopa induced dyskinesia, neurodegenerative eye disease, Parkinson’s disease, rett syndrome, fragile X, and Alzheimer’s disease. The company was founded in 2018 and is based in the Netherlands.
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses.
Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.
Flyp, Inc. is a telecommunications company based in the United States that aims to enhance the global consumer communications experience. It offers a proprietary platform that allows users to manage multiple phone numbers on a single device while providing high-quality voice and text communications, both in-network and out-of-network. Notably, Flyp serves international customers by offering a unique solution that provides a local US phone number, enabling mobile users to make free calls and send texts to and from any US phone number. This innovative approach allows users to consolidate their mobile communications into one streamlined application, facilitating hassle-free interactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.